NTBC 2 mg (Orfadin 2 mg)
Generic Name: nitisinone
Pill imprint NTBC 2 mg has been identified as Orfadin 2 mg.
Orfadin is used in the treatment of hereditary tyrosinemia type 1 and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Orfadin 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
Orfadin
- Generic Name:
- nitisinone
- Imprint:
- NTBC 2 mg
- Strength:
- 2 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous metabolic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Rare Disease Therapeutics Inc
- National Drug Code (NDC):
- 66621-1002
- Inactive Ingredients:
- titanium dioxide
gelatin
More about Orfadin (nitisinone)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
